New York State Common Retirement Fund cut its holdings in Rockwell Medical, Inc. (NASDAQ:RMTI) by 0.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 40,600 shares of the company’s stock after selling 1 shares during the period. New York State Common Retirement Fund owned about 0.08% of Rockwell Medical worth $322,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Teachers Advisors LLC raised its holdings in shares of Rockwell Medical by 1.5% in the second quarter. Teachers Advisors LLC now owns 88,772 shares of the company’s stock valued at $704,000 after purchasing an additional 1,335 shares during the last quarter. TIAA CREF Investment Management LLC raised its holdings in shares of Rockwell Medical by 1.1% in the second quarter. TIAA CREF Investment Management LLC now owns 132,131 shares of the company’s stock valued at $1,048,000 after purchasing an additional 1,401 shares during the last quarter. Cutter & CO Brokerage Inc. raised its holdings in shares of Rockwell Medical by 6.3% in the second quarter. Cutter & CO Brokerage Inc. now owns 25,325 shares of the company’s stock valued at $201,000 after purchasing an additional 1,500 shares during the last quarter. American International Group Inc. raised its holdings in shares of Rockwell Medical by 7.1% in the first quarter. American International Group Inc. now owns 29,509 shares of the company’s stock valued at $185,000 after purchasing an additional 1,955 shares during the last quarter. Finally, Balasa Dinverno & Foltz LLC raised its holdings in shares of Rockwell Medical by 5.8% in the second quarter. Balasa Dinverno & Foltz LLC now owns 54,300 shares of the company’s stock valued at $431,000 after purchasing an additional 3,000 shares during the last quarter. Institutional investors own 21.73% of the company’s stock.

RMTI has been the topic of a number of recent research reports. BidaskClub downgraded shares of Rockwell Medical from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Zacks Investment Research downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a report on Wednesday. Finally, Ifs Securities initiated coverage on shares of Rockwell Medical in a report on Monday, August 14th. They issued a “strong-buy” rating and a $11.00 price objective on the stock.

Shares of Rockwell Medical, Inc. (NASDAQ RMTI) opened at $6.39 on Friday. Rockwell Medical, Inc. has a fifty-two week low of $5.06 and a fifty-two week high of $8.98.

Rockwell Medical (NASDAQ:RMTI) last released its earnings results on Wednesday, November 8th. The company reported ($0.10) earnings per share for the quarter, meeting the consensus estimate of ($0.10). Rockwell Medical had a negative net margin of 39.28% and a negative return on equity of 46.63%. The business had revenue of $14.63 million during the quarter, compared to analysts’ expectations of $13.33 million. During the same period last year, the business earned ($0.09) earnings per share. The firm’s revenue was up 14.2% on a year-over-year basis. analysts forecast that Rockwell Medical, Inc. will post -0.44 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “New York State Common Retirement Fund Sells 1 Shares of Rockwell Medical, Inc. (RMTI)” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://theolympiareport.com/2017/11/19/new-york-state-common-retirement-fund-sells-1-shares-of-rockwell-medical-inc-rmti.html.

Rockwell Medical Profile

Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.

Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.